AIM

Fiyat (1 Yıl)

Katılım Finansı Tarama Oranları

Oranlar AAOIFI tabanlı tarama dosyasından alınmıştır; fetva niteliği taşımaz.

Şirket Hakkında

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts.